From application to approval: What makes Bankful different for CBD, peptides, and regulated sellers

If you sell CBD, peptides, nutraceuticals, or other regulated products online, you already know the hardest part of scaling isn’t marketing.

It’s payments.

High-risk merchants don’t struggle because their products don’t sell. They struggle because:

• Applications get declined without explanation
• Accounts get approved — then shut down months later
• Underwriting changes mid-stream
• Reserves suddenly increase
• Policies shift without warning

And most of the time, it isn’t because the merchant did something wrong.

It’s because the processor never truly understood the business in the first place.

Let’s break down what makes the difference.

Most payment processors underwrite categories. Bankful underwrites businesses.

Traditional processors look at your industry label and make a quick risk decision:

CBD? High-risk.
Peptides? High-risk.
Supplements? Moderate-to-high risk.

Decision made.

But regulated industries aren’t all the same.

There’s a major difference between:

• A compliant CBD topical brand with COAs and clean marketing
• A peptide research brand properly labeled “research use only”
• A merchant making aggressive medical claims

Most processors don’t take the time to distinguish that nuance.

Bankful does.

We look at:

• Product mix
• Marketing language
• Fulfillment model
• Chargeback exposure
• Subscription structure
• Customer acquisition strategy
• Regulatory posture

That’s how approvals become stable — not temporary.

• 62%

  Of high-risk merchants report experiencing at least one unexpected account review, freeze, or shutdown

• 3–5x

  Restricted industries are up to three to five times more likely to face enhanced underwriting requirements

• 47%

  Of CBD and supplement sellers say payment instability has directly impacted revenue or advertising

From application to approval: What actually happens

For regulated merchants, approval isn’t just about submitting an application.

It’s about structuring the business correctly before underwriting ever sees it.

When merchants come to us, we don’t just ask for documents. We look at:

• Website compliance
• Terms and conditions
• Refund policy clarity
• Claims language
• Product categorization
• Traffic sources

We identify potential red flags before they become underwriting problems.

This dramatically reduces:

• Surprise declines
• Re-underwriting reviews
• Sudden account freezes
• Reserve spikes

Approval isn’t the goal. Stable approval is.

Why CBD and peptide sellers get shut down elsewhere

The biggest reason high-risk merchants lose processing is not fraud.

It’s mismatch.

A processor approves the account without fully understanding:

• Cannabinoid variations
• Peptide classifications
• Research-only labeling standards
• Card network monitoring programs
• Advertising compliance thresholds

Then policy shifts.

Or Visa updates enforcement.

Or a risk team audits accounts.

And the merchant gets flagged.

This cycle repeats constantly in high-risk industries.

Bankful’s model is different because we specialize in these categories. We understand:

• The difference between intoxicating and non-intoxicating cannabinoids
• How peptide merchants should position products
• How card networks view subscription models
• Where chargeback risk actually comes from

That specialization protects merchants long term.

Stability matters more than speed

Some processors promise fast approvals.

But speed without category understanding leads to instability.

For CBD and peptide merchants, stability means:

• Predictable underwriting
• Transparent reserve structures
• Proactive communication
• Real human support
• Guidance when regulations evolve

The goal isn’t just getting you live.

The goal is keeping you live.

Regulatory industries require a different kind of payment partner

CBD.
Peptides.
Nutraceuticals.
Functional wellness.
Emerging regulated categories.

These industries will always face scrutiny.

But scrutiny doesn’t mean impossibility.

It means you need a processor who:

⭐ Understands evolving regulations
⭐ Knows how banks and card networks evaluate risk
⭐ Reviews your business holistically
⭐ Prepares you for compliance shifts
⭐ Doesn’t panic when policy headlines hit

That’s the difference between reactive processing and strategic processing.

What makes us different

Bankful was built specifically for merchants others overlook.

From application to approval, we focus on:

• Education, not just documentation
• Risk management, not just revenue
• Long-term approval, not quick sign-offs
• Category expertise, not generic underwriting

We don’t treat CBD or peptides as labels.

We treat them as industries.

And that’s why our merchants stay approved when others don’t.

If you sell in a regulated category, you don’t just need a gateway.

You need a partner who understands your vertical, anticipates policy shifts, and structures your approval correctly from day one.

From application to approval — and beyond — the difference is expertise.

If you’re ready to work with a processor built for CBD, peptides, and regulated sellers, connect with our team to start the conversation.